(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 19.19% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Natera's revenue in 2026 is $2,116,674,000.On average, 24 Wall Street analysts forecast NTRA's revenue for 2026 to be $366,290,390,110, with the lowest NTRA revenue forecast at $335,237,135,485, and the highest NTRA revenue forecast at $394,583,355,435. On average, 23 Wall Street analysts forecast NTRA's revenue for 2027 to be $434,331,521,355, with the lowest NTRA revenue forecast at $343,379,988,920, and the highest NTRA revenue forecast at $486,086,945,730.
In 2028, NTRA is forecast to generate $491,055,466,470 in revenue, with the lowest revenue forecast at $448,270,982,320 and the highest revenue forecast at $542,672,876,380.